Peter Attia· MD
we had to make the world's best assays to look at each of these features um and then we had to process all of those samples and then analyze them and you know we did it in a very rigorous way where the final testing was all done blinded and the analysis was all done blinded so we could be sure that um you know the the results you know um were not biased uh and then we compared them all and we also compared them in combinations and we use sophisticated machine learning approaches to really maximize the the use of the of each individual type of data from from each you know whether or not it was mutations or the chromosomal changes or methylation